Correlation Between Nuvalent and Silverback Therapeutics
Can any of the company-specific risk be diversified away by investing in both Nuvalent and Silverback Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nuvalent and Silverback Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nuvalent and Silverback Therapeutics, you can compare the effects of market volatilities on Nuvalent and Silverback Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nuvalent with a short position of Silverback Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nuvalent and Silverback Therapeutics.
Diversification Opportunities for Nuvalent and Silverback Therapeutics
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Nuvalent and Silverback is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Nuvalent and Silverback Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Silverback Therapeutics and Nuvalent is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nuvalent are associated (or correlated) with Silverback Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Silverback Therapeutics has no effect on the direction of Nuvalent i.e., Nuvalent and Silverback Therapeutics go up and down completely randomly.
Pair Corralation between Nuvalent and Silverback Therapeutics
Given the investment horizon of 90 days Nuvalent is expected to generate 4.46 times less return on investment than Silverback Therapeutics. But when comparing it to its historical volatility, Nuvalent is 1.24 times less risky than Silverback Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Silverback Therapeutics is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 630.00 in Silverback Therapeutics on November 3, 2024 and sell it today you would earn a total of 672.00 from holding Silverback Therapeutics or generate 106.67% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Nuvalent vs. Silverback Therapeutics
Performance |
| Timeline |
| Nuvalent |
| Silverback Therapeutics |
Nuvalent and Silverback Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Nuvalent and Silverback Therapeutics
The main advantage of trading using opposite Nuvalent and Silverback Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nuvalent position performs unexpectedly, Silverback Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Silverback Therapeutics will offset losses from the drop in Silverback Therapeutics' long position.| Nuvalent vs. Arcellx | Nuvalent vs. Vaxcyte | Nuvalent vs. Viridian Therapeutics | Nuvalent vs. Ventyx Biosciences |
| Silverback Therapeutics vs. Zura Bio Limited | Silverback Therapeutics vs. Annexon | Silverback Therapeutics vs. In8bio Inc | Silverback Therapeutics vs. Wave Life Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |